SCHEMBL6544171

SCHEMBL6544171

N#Cc1ccc(Oc2ccc(N)c(CN)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP15 Q460N3 1/20 0.45
PARP10 Q53GL7 1/20 0.45
PARP2 Q9UGN5 1/20 0.45
LOXL2 Q9Y4K0 1/20 0.43
NR4A1 P22736 1/20 0.41
CYP19A1 P11511 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
IL18 Q14116 1/20 0.41
CHRM1 P11229 1/20 0.40
PDE4A P27815 1/20 0.40
ADRA1A P35348 1/20 0.40
PDE1A P54750 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20476347 0.86 PARP15 (0.47) PARP15PARP10PARP2NR4A1CYP19A1
SCHEMBL20982556 0.81 NR4A1 (0.65) PARP15PARP10PARP2NR4A1CYP19A1
SCHEMBL18402908 0.80 PARP15 (0.42) PARP15PARP10PARP2NR4A1CYP19A1
SCHEMBL860477 0.78 PARP15 (0.49) PARP15PARP10PARP2NR4A1CYP19A1
SCHEMBL18402909 0.78 KCNH2 (0.38) PARP15PARP10PARP2CYP19A1KDM4E
SCHEMBL18402935 0.76 PDE4B (0.43) PARP15PARP10PARP2CYP19A1KDM4E
SCHEMBL4371816 0.75 LOXL2 (0.76) PARP15PARP10PARP2LOXL2CYP19A1
SCHEMBL18402934 0.75 CHRM1 (0.37) PARP15PARP10PARP2CYP19A1KDM4E
SCHEMBL7041250 0.74 PARP15 (0.63) PARP15PARP10PARP2LOXL2CYP19A1
SCHEMBL8852392 0.74 PARP15 (0.63) PARP15PARP10PARP2LOXL2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1022272-B1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS SANKYO CO (JP) 2004-05-26 EP disclosed
US-6432993-B1 BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 2002-08-13 US disclosed
EP-1022272-A1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS Sankyo Company Limited (JP) 2000-07-26 EP disclosed